Search Login Register

Cavernous Hemangioma (Cavernous Angioma) Summary

Description: A vascular anomaly that is a collection of tortuous BLOOD VESSELS and connective tissue. This tumor-like mass with the large vascular space is filled with blood and usually appears as a strawberry-like lesion in the subcutaneous areas of the face, extremities, or other regions of the body including the central nervous system.

Also Known As: Cavernous Angioma; Cavernous Hemangiomas; Hemangioma, Cavernous; Strawberry Hemangiomas; Hemangioma, Strawberry Show All >>

Networked: 409 relevant articles (12 outcomes, 26 trials/studies) for this Disease

Key Drugs and Agents for Cavernous Hemangioma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. bleomycetin : 1 outcome 2 studies in 6 results : IBA
  2. Retinaldehyde (Retinal) : 1 outcome 1 study in 30 results : IBA
  3. Cosmetics : 1 outcome 1 study in 5 results : IBA
  4. Kasabach-Merritt Syndrome : 1 outcome in 18 results : IBA
  5. Argon : 1 outcome in 6 results : IBA
  6. Colloids (Colloid) : 1 outcome in 2 results : IBA
  7. Microangiopathic hemolytic anemia : 1 outcome in 2 results : IBA
  8. Sulfur : 1 outcome in 1 result : IBA
  9. Cytidine Triphosphate (CTP) : 1 outcome in 1 result : IBA
  10. Blood Coagulation Factors (Coagulation Factor) : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Cavernous Hemangioma

  1. Neoplasms (Cancer)
  2. Hemangioma (Angioma)
  3. Disseminated Intravascular Coagulation
  4. Port-Wine Stain (Nevus Flammeus)
  5. Thrombocytopenia (Thrombopenia)
Show All >>

Key Therapies for Cavernous Hemangioma

Efficacy Chart >>
  1. Ligation : 2 outcomes in 5 results
  2. Radiotherapy : 1 outcome 2 studies in 20 results
  3. Hepatectomy : 1 outcome 1 study in 12 results
  4. Laser Therapy (Surgery, Laser) : 1 outcome in 7 results
  5. Sutures (Suture) : 1 outcome in 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.